Previous close | 2.0000 |
Open | 2.3200 |
Bid | 2.2000 |
Ask | 2.7000 |
Strike | 27.50 |
Expiry date | 2024-05-17 |
Day's range | 2.1500 - 2.5000 |
Contract range | N/A |
Volume | |
Open interest | 180 |
BALTIMORE, May 20, 2024--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, today announced the launch of the first phase of its multimillion-dollar national marketing campaign. The campaign will highlight OPTAVIA’s new offering in collaboration with LifeMD®, the GLP-1 Lifestyle Program, a holistic approach to medical weight loss specifically tailored to support the needs of those utilizing GLP-1 medications. This robust
Medifast, Inc. (NYSE:MED) Q1 2024 Earnings Call Transcript April 29, 2024 Medifast, Inc. misses on earnings expectations. Reported EPS is $0.66 EPS, expectations were $0.78. MED isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to the Medifast First […]